Lutz Robert Matthew
Transaction: 07/15/2026
BUY
Change
+70,000
Price
$5.81
Filing
07/24/2026
Type
BUY
Savara Inc.
SVRA • Biotechnology
$4.82
▲ +0.06 (+1.24%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$1.26B
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.15Healthy liquidity · 11.85Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:51 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.82
Change1.24%
Shares Out253.57M
Market Cap$1.26B
Enterprise Value$1.12B
52W Range2.92 - 7.00
Beta0.26
P/E-9.04
P/B8.76
P/FCF-11.38
EV/EBITDA-7.82
EV/FCF-10.09
Price$4.82
Change1.24%
Shares Out253.57M
Market Cap$1.26B
Enterprise Value$1.12B
52W Range2.92 - 7.00
Beta0.26
P/E-9.04
P/B8.76
P/FCF-11.38
EV/EBITDA-7.82
EV/FCF-10.09
Earnings Yield-11.07%
FCF Yield-8.79%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.15
Current Ratio11.85
Quick Ratio11.85
Target$10.00
Target Upside107.50%
Target Median$10.00
Target Range10.00 - 10.00
Volume1.87M
Avg Volume1.60M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
39
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score▼
Manageable debt level · 0.15Healthy liquidity · 11.85Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 11 analyst votes · 2026-10-20
91/100
Bullish
Bullish
9
Hold
2
Bearish
0
Price Target
2026-08-14
Low
$10.00
Mean
$10.00
Median
$10.00
High
$10.00
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Lutz Robert Matthew
Transaction: 07/15/2026
BUY
Change
+35,000
Price
Not reported
Filing
07/24/2026
Type
BUY
Lowrance David L
Transaction: 06/22/2026
SELL
Change
-75,000
Price
$1.59
Filing
06/22/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Lutz Robert Matthew | BUY | +70,000 | $5.81 | 07/15/2026 | 07/24/2026 |
| Lutz Robert Matthew | BUY | +35,000 | Not reported | 07/15/2026 | 07/24/2026 |
| Lowrance David L | SELL | -75,000 | $1.59 | 06/22/2026 | 06/22/2026 |
| Lowrance David L | SELL | -394,528 | $5.68 | 06/22/2026 | 06/22/2026 |
| Lowrance David L | SELL | -80,684 | $1.51 | 03/18/2026 | 03/20/2026 |
| Lowrance David L | SELL | -24,174 | $5.04 | 03/18/2026 | 03/20/2026 |
| McCracken Joseph S | SELL | -1,807 | $1.76 | 02/16/2026 | 02/17/2026 |
| McCracken Joseph S | BUY | +1,807 | $1.76 | 02/16/2026 | 02/17/2026 |
| RAMSAY DAVID A | SELL | -20,000 | $6.06 | 12/19/2025 | 12/19/2025 |
| Pauls Matthew | SELL | -128,995 | Not reported | 12/16/2025 | 12/16/2025 |
| Lowrance David L | SELL | -32,000 | Not reported | 12/16/2025 | 12/16/2025 |
| Erickson Anne | SELL | -62,960 | $6.92 | 12/14/2025 | 12/16/2025 |
| McCabe Kathleen R. | SELL | -39,350 | $6.92 | 12/14/2025 | 12/16/2025 |
| Lutz Robert Matthew | SELL | -67,760 | $6.92 | 12/14/2025 | 12/16/2025 |
| Pauls Matthew | SELL | -195,705 | $6.92 | 12/14/2025 | 12/16/2025 |
| Lowrance David L | SELL | -62,960 | $6.92 | 12/14/2025 | 12/16/2025 |
| Pauls Matthew | SELL | -23,629 | Not reported | 12/10/2025 | 12/11/2025 |
| McCracken Joseph S | BUY | +40,000 | Not reported | 12/09/2025 | 12/11/2025 |
| RAMSAY DAVID A | BUY | +40,000 | Not reported | 12/09/2025 | 12/11/2025 |
| Elam Nevan C | BUY | +40,000 | Not reported | 12/09/2025 | 12/11/2025 |